课题基金 / 基金详情

High resolution analysis of proteins associated with the induction of cell death and carcinogenesis of tumor cells development of chemopreventive agents

High resolution analysis of proteins associated with the induction of cell death and carcinogenesis of tumor cells development of chemopreventive agents
与诱导细胞死亡和肿瘤细胞致癌相关的蛋白质的高分辨率分析 化学预防剂的开发
批准号:
15590068
负责人:
NAKAYA Kazuyasu
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

NAKAYA Kazuyasu的其他基金

相似基金

相关文献

中文摘要
翻译
β-羟基异戊基紫草素(β-HIVS)是一种对v-Src和EGFR等蛋白酪氨酸激酶的非竞争性抑制物,可诱导多种肿瘤细胞系的凋亡。为了阐明诱导细胞凋亡的机制和开发化学预防药物,对对β敏感的人肺癌DMS114细胞株进行了β-HIVS处理,并用磷酸蛋白纯化柱分离磷酸化蛋白后,用2D-PAGE分析了诱导细胞凋亡的蛋白质。当5μMβ-HIVS作用于DMS114细胞时,我们发现2D凝胶中有一个斑点明显减少,并经质谱仪鉴定为dUTP核苷酸脱氢酶(DUTPase)。免疫印迹证实β-HIVS处理后dUTP酶活性降低。将抗dUTPase的小干扰RNA导入DMS114细胞,可增强β-HIVS诱导的细胞凋亡。β-HIVS处理DMS114细胞30min后,dUTP酶活性显著降低。顺铂、喜树碱和足叶乙甙等其他诱导细胞凋亡的药物不能引起dUTPase的降低,提示dUTPase的降低作用是β-HIVs所特有的。β-HIV与胸苷合成酶特异性抑制剂5-氟尿嘧啶(5-FU)联合作用于DMS114细胞,观察其诱导细胞凋亡的相加作用。这些结果提示,毒性较低的β-HIV或其衍生物可能适合于化学预防。
英文摘要
β-Hydroxyisovalerylshikonin (β-HIVS) is an ATP-noncompetitive inhibitor for protein tyrosine kinases such as v-Src and EGFR and induces apoptosis in various lines of human tumor cells. For elucidating of the mechanism of the induction of apoptosis and developing chemopreventive agents, a human lung cancer DMS114 cell line, which is one of the most sensitive to β-HIVS, was treated with β-HIVS and proteins responsible for the induction of apoptosis was analyzed by 2D-polyacrylamide gel electrophoresis (2D-PAGE) after separation of phosphoproteins using phosphoprotein purification column. When DMS114 cells were treated with 5 μM β-HIVS, we found that one spot in 2D gel was decreased markedly and identified this by mass spectrometry as dUTP nucleotidehydrolase (dUTPase). The decrease of dUTPase by the treatment with β-HIVS was confirmed by immunoblotting of the eluate fraction from the phosphoprotein purification column. Transfection of DMS114 cells with siRNA against dUTPase enhanced the induction of apoptosis by treatment with β-HIVS. The activity of dUTPase was markedly decreased immediately 30 min after treatment of DMS114 cells with β-HIVS. The reduction of dUTPase in DMS114 cells were not caused by other inducers of apoptosis such as cisplatin, camptothecin, and etoposide (VP16), suggesting that the dUTPase-decreasing effect is specific to the action of β-HIVS. Additive effects on the induction of apoptosis was observed by combined treatment of DMS114 cells with β-HIVS and 5-fluorouracil (5-FU), which is a specific inhibitor of thymidylate synthase. These results suggest that β-HIVS or its derivative with lower toxicity may be suitable for chemopreventive.
期刊论文(55)
专著(0)
科研奖励(0)
会议论文
Kazuyasu Nakaya et al.: "β-Hydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1"Oncogene. 22(7). 1012-1023 (2003)
Kazuyasu Nakaya 等人:“β-羟基异戊酰紫草素通过抑制 Polo 样激酶 1 的活性诱导人白血病细胞凋亡”Oncogene 1012-1023 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
A shikoni derivative, β-hydroxyisovalerylshikonin, is an ATP-non-competitive inhibitor of protein tyrosine kinases.
紫草衍生物 β-羟基异戊酰紫草素是一种 ATP 非竞争性蛋白酪氨酸激酶抑制剂。
DOI: --
发表时间: 2003
期刊: Anti-Cancer Drugs 14・9
影响因子: --
作者: [Yutaka Masuda, Genryu Shima, Toshihiro Aiuchi, Masayo Horie, Koichi Hori, Shigeo Nakajo, Toshiko Sachiko Kajimotc Shibayama-lmazu, Kazuyasu Nakaya, Kazuyasu Nakaya, Takao Suzuki et al., Yutaka Masuda et al., 中谷一泰, Yutaka Masuda et al., Toshiko Shibayama-Imazu et al., Kazuyasu Nakaya]
通讯作者: Kazuyasu Nakaya
DOI: 10.1128/iai.72.4.1856-1865.2004
发表时间: 2004-04-01
期刊: INFECTION AND IMMUNITY
影响因子: 3.1
作者: [Suzuki, T, Kobayashi, M, Hasegawa, K]
通讯作者: Hasegawa, K
抗癌剤・神経変性剤・味覚変換剤開発のための基礎研究
抗癌药、神经退行性疾病药、味觉改变剂开发的基础研究
DOI: --
发表时间: 2004
期刊: 薬学雑誌 124・7
影响因子: --
作者: [Ying Xu et al., Tsuyoshi Kobayashi et al., Takao Suzuki et al., Yutaka Masuda et al., 中谷一泰]
通讯作者: 中谷一泰
共 16 条
    Development of a novel anti-cancer agent from a novel tyrosine kinase inhibitor
    • 批准号:
      13672297
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2001
    • 负责人:
      NAKAYA Kazuyasu
    • 依托单位:
    Studies on apoptosis-inducers targeted for the molecules associated with the induction of apoptosis in cancer cells
    • 批准号:
      11672182
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      1999
    • 负责人:
      NAKAYA Kazuyasu
    • 依托单位:
    Effects of isoprenoid compounds on human solid cancer cells
    • 批准号:
      09672251
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.92万
    • 财政年份:
      1997
    • 负责人:
      NAKAYA Kazuyasu
    • 依托单位:
    Combined effects of differentiation-apoptosis inducers on mice inoculated with human leukemia cells.
    • 批准号:
      06672239
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1994
    • 负责人:
      NAKAYA Kazuyasu
    • 依托单位:
    国内基金
    海外基金
    基于CRISPR/Cas9的羊口疮病毒dUTPase基因缺失株构建及其生物学特性
    • 批准号:
      31602063
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      18.0万元
    • 批准年份:
      2016
    • 负责人:
      王勇
    • 依托单位:
    基于对虾白斑综合症病毒dUTPase结构的抑制剂设计及抗病毒活性研究
    • 批准号:
      31572660
    • 项目类别:
      面上项目
    • 资助金额:
      62.0万元
    • 批准年份:
      2015
    • 负责人:
      马庆军
    • 依托单位: